New drug combo targets Hard-to-Treat GI cancers
Disease control
Recruiting now
This study is for people with advanced or metastatic gastrointestinal cancers, including anal and pancreatic cancers. Researchers are testing a combination of two drugs, pelareorep and atezolizumab, to see if they are safe and can shrink tumors or slow disease growth. About 122 p…
Phase: PHASE1, PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated May 13, 2026 16:01 UTC